Who owns the RYSDEO MYCITE trademark?

The RYSDEO MYCITE trademark is owned by Otsuka Pharmaceutical Co., Ltd..

What is the serial number for RYSDEO MYCITE?

The USPTO serial number for RYSDEO MYCITE is 79292766.

What is the registration number for RYSDEO MYCITE?

RYSDEO MYCITE is registered under USPTO registration number 6443522.

RYS

USPTO Trademark Record

REGISTERED

RYSDEO MYCITE

Q: What class is the RYSDEO MYCITE trademark registered in?

The RYSDEO MYCITE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

SN 79292766·Reg 6443522·Filed Jun 24, 2020

Owner Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

RYSDEO MYCITE (Serial No. 79292766), Registration No. 6443522, is a registered US trademark filed on Jun 24, 2020 by Otsuka Pharmaceutical Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 010 (Surgical, medical, dental & veterinary apparatus).

Renewal window: August 10, 2027306 days remaining

Mark Intelligence

RYSDEO MYCITE (Reg. #6443522) is a registered US trademark that has been protecting its owner, Otsuka Pharmaceutical Co., Ltd., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 010 (Surgical, medical, dental & veterinary apparatus) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Jun 24, 2020

SERIAL

79292766

REG#

6443522

REGISTERED

Aug 10, 2021

Owner

Applicant

Otsuka Pharmaceutical Co., Ltd.

Entity

Corporation

Address

2-9 Kanda-Tsukasamachi,, Chiyoda-ku Tokyo 101-8535

Country

Attorney

NameScott S. Havlick

Law firm

Scott S. Havlick Holland & Hart LLP

Docket

93346.0106

Address

P.O. Box 8749, TM Docketing, Attn: Trademark Docketing, Denver, CO 80201, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 24, 2020

Serial Number79292766

Registration No.6443522

Registration DateAug 10, 2021

Status DateAug 10, 2021

Published for OppositionMay 25, 2021

Mark TypeStandard characters

Attorney Docket93346.0106

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 010Surgical, medical, dental & veterinary apparatus

US codes: 026, 039, 044

Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; spectacles, contact lenses and sunglasses; orthopaedic articles; suture materials; therapeutic and assistive devices adapted for persons with disabilities; massage apparatus; apparatus, devices and articles for nursing infants; sexual activity apparatus, devices and articles.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

31 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Aug 10, 2026

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

NEW REPRESENTATIVE AT IB RECEIVED

Mar 13, 2023

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DECISION TRANSACTION PROCESSED BY IB

Feb 14, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jan 20, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jan 20, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Nov 10, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Aug 10, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

May 25, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 25, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

May 23, 2021

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 05, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

May 05, 2021

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

May 05, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 16, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 15, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 15, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 15, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Nov 14, 2020

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Oct 28, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 28, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 27, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Oct 26, 2020

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

Oct 23, 2020

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 01, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 30, 2020

NON-FINAL ACTION WRITTEN

Sep 30, 2020

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 27, 2020

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Sep 15, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 11, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Sep 08, 2020

LIMITATION FROM ORIGINAL APPLICATION ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Sep 03, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

RYSDEO MYCITE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Otsuka Pharmaceutical Co., Ltd.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Scott S. Havlick

Resources

Company